Page last updated: 2024-08-17

2,3,4,6-tetrachlorophenol and cytochrome c-t

2,3,4,6-tetrachlorophenol has been researched along with cytochrome c-t in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kim, EC; Kim, YM; Kwon, YG; Lee, KS; Min, JK; Ryoo, IJ; Won, MH; Yoo, I-; Yun, BS	1

Other Studies

1 other study(ies) available for 2,3,4,6-tetrachlorophenol and cytochrome c-t

Article	Year
Complestatin prevents apoptotic cell death: inhibition of a mitochondrial caspase pathway through AKT/PKB activation. Biochemical and biophysical research communications, 2004, Jan-02, Volume: 313, Issue:1 Topics: Apoptosis; Apoptosis Regulatory Proteins; BH3 Interacting Domain Death Agonist Protein; Carrier Proteins; Caspase Inhibitors; Caspases; Cell Survival; Chlorophenols; Cytochromes c; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; HeLa Cells; Humans; Immunoblotting; Membrane Glycoproteins; Mitochondria; Peptides, Cyclic; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha	2004

Article

Year

Complestatin prevents apoptotic cell death: inhibition of a mitochondrial caspase pathway through AKT/PKB activation.

Biochemical and biophysical research communications, 2004, Jan-02, Volume: 313, Issue:1

Topics: Apoptosis; Apoptosis Regulatory Proteins; BH3 Interacting Domain Death Agonist Protein; Carrier Proteins; Caspase Inhibitors; Caspases; Cell Survival; Chlorophenols; Cytochromes c; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; HeLa Cells; Humans; Immunoblotting; Membrane Glycoproteins; Mitochondria; Peptides, Cyclic; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha

2004